Key result
Spp1 silencing reduces infarct volume and alleviates neuroinflammation after ischemic stroke in mice.
Why the study?
Does Spp1 silencing reduce microglia-mediated synaptic engulfment and improve outcomes in a mouse model of ischemic stroke?
Does Spp1 silencing reduce microglia-mediated synaptic engulfment and improve outcomes in a mouse model of ischemic stroke?
Targeting perivascular SPP1 suppresses excessive microglia-mediated synaptic engulfment and preserves BBB integrity in a mouse model of ischemic stroke.
OBJECTIVE: Following ischemic stroke (IS), activated microglia activity could contribute to neuronal injury and blood-brain barrier (BBB) disruption. The upstream vascular-derived signal initiating this transition remains unclear; therefore, we investigated whether perivascular SPP1 regulates microglia-mediated synapse engulfment during IS. METHODS: Male C57BL/6 mice were assigned to sham, shSpp1, middle cerebral artery occlusion/reperfusion (MCAO/R), and MCAO/R + shSpp1 groups. Cerebral perfusion was assessed using laser speckle contrast imaging and super-resolution vascular imaging, while neuronal injury was evaluated using Nissl and TUNEL staining. Proteomic profiling of the ischemic penumbra identified regulators of microglia-mediated synaptic remodeling. Synaptic structure and glial-vascular unit (GVU) integrity were examined using transmission electron microscopy, immunofluorescence, and molecular analyses. Behavioral outcomes were assessed using the open-field, Barnes maze, rotarod, and wire-hanging tests. RESULTS: Compared with sham controls, MCAO/R mice displayed increased microglial synaptic engulfment and ultrastructural synaptic damage in the ischemic penumbra, accompanied by reduced synaptic protein expression. Proteomic analysis revealed upregulation of inflammatory and vascular-related pathways, with marked upregulation of SPP derived from perivascular macrophages. Spp1 silencing attenuated neuroinflammation, reduced infarct volume, improved cerebral perfusion, preserved GVU integrity, and alleviated behavioral deficits. Spp1 suppression also reduced microglial synaptic engulfment in vivo and restored synaptic protein and mRNA levels in vitro. CONCLUSION: Targeting perivascular SPP1 suppresses excessive microglia-mediated synaptic engulfment, preserves BBB integrity and synaptic architecture, and offers a GVU-centered therapeutic strategy for IS.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied Ischemic stroke. Spp1 silencing (shSpp1) vs. Sham and MCAO/R controls was evaluated on Microglial synaptic engulfment, infarct volume, cerebral perfusion, and behavioral deficits. Spp1 silencing attenuated neuroinflammation, reduced infarct volume, improved cerebral perfusion, preserved glial-vascular unit integrity, and alleviated behavioral deficits in a mouse model of ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: